BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1692469)

  • 1. C595--a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas.
    Price MR; Pugh JA; Hudecz F; Griffiths W; Jacobs E; Symonds IM; Clarke AJ; Chan WC; Baldwin RW
    Br J Cancer; 1990 May; 61(5):681-6. PubMed ID: 1692469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an anti-idiotypic antibody reactive with an antibody defining the epitope RPAP in the MUC-1 epithelial mucin core.
    Bashford JL; Robins RA; Price MR
    Int J Cancer; 1993 Jul; 54(5):778-83. PubMed ID: 7686886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological and structural features of the protein core of human polymorphic epithelial mucin.
    Price MR; Hudecz F; O'Sullivan C; Baldwin RW; Edwards PM; Tendler SJ
    Mol Immunol; 1990 Aug; 27(8):795-802. PubMed ID: 1698259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple epitopes on a human breast-carcinoma-associated antigen.
    Price MR; Edwards S; Owainati A; Bullock JE; Ferry B; Robins RA; Baldwin RW
    Int J Cancer; 1985 Nov; 36(5):567-74. PubMed ID: 2414233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of anti-epithelial mucin monoclonal antibodies by epitope affinity chromatography.
    Price MR; Sekowski M; Tendler SJ
    J Immunol Methods; 1991 May; 139(1):83-90. PubMed ID: 1710253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope analysis of monoclonal antibody NCRC-11 defined antigen isolated from human ovarian and breast carcinomas.
    Price MR; Edwards S; Powell M; Baldwin RW
    Br J Cancer; 1986 Sep; 54(3):393-400. PubMed ID: 2428391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies reactive with the breast carcinoma-associated mucin core protein repeat sequence peptide also recognise the ovarian carcinoma-associated sebaceous gland antigen.
    Layton GT; Devine PL; Warren JA; Birrell G; Xing PX; Ward BG; McKenzie IF
    Tumour Biol; 1990; 11(5):274-86. PubMed ID: 1697426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mucin antigens: what are we measuring?
    Price MR; Briggs S; Scanlon MJ; Tendler SJ; Sibley PE; Hand CW
    Dis Markers; 1991; 9(3-4):205-12. PubMed ID: 1725974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies reactive with mucin expressed in breast cancer.
    Xing PX; Tjandra JJ; Stacker SA; Teh JG; Thompson CH; McLaughlin PJ; McKenzie IF
    Immunol Cell Biol; 1989 Jun; 67 ( Pt 3)():183-95. PubMed ID: 2477330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin.
    Ho JJ; Bi N; Yan PS; Yuan M; Norton KA; Kim YS
    Cancer Res; 1991 Jan; 51(1):372-80. PubMed ID: 1703039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and immunochemical analysis of a breast carcinoma associated antigen defined by the monoclonal antibody NCRC-11.
    Price MR
    Arch Geschwulstforsch; 1987; 57(3):177-80. PubMed ID: 2441681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine specificity of antibody recognition of carcinoma-associated epithelial mucins: antibody binding to synthetic peptide epitopes.
    Briggs S; Price MR; Tendler SJ
    Eur J Cancer; 1993; 29A(2):230-7. PubMed ID: 7678496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide epitope binding and fluorescence quenching with the anti-mucin antibody C595.
    Scanlon MJ; Price MR; Tendler SJ
    Cancer Lett; 1992 Apr; 63(3):199-202. PubMed ID: 1374287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product.
    Burchell J; Taylor-Papadimitriou J
    Epithelial Cell Biol; 1993 Oct; 2(4):155-62. PubMed ID: 7505698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of monoclonal-antibody-defined antigens in fractions isolated from human breast carcinomas and patients' serum.
    Croce MV; Price MR; Segal-Eiras A
    Cancer Immunol Immunother; 1995 Feb; 40(2):132-7. PubMed ID: 7882384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of polymorphic epithelial mucins in the serum of systemic breast cancer patients using the monoclonal antibody, NCRC-11.
    Price MR; Clarke AJ; Robertson JF; O'Sullivan C; Baldwin RW; Blamey RW
    Cancer Immunol Immunother; 1990; 31(5):269-72. PubMed ID: 2376045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-colorectal carcinoma monoclonal antibodies reactive with human milk fat globular membranes.
    Teh JG; Xing PX; McKenzie IF
    Immunol Cell Biol; 1990 Jun; 68 ( Pt 3)():207-16. PubMed ID: 1699885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second generation anti-MUC1 peptide monoclonal antibodies.
    Xing PX; Prenzoska J; Quelch K; McKenzie IF
    Cancer Res; 1992 Apr; 52(8):2310-7. PubMed ID: 1373108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2.
    Stacker SA; Tjandra JJ; Xing PX; Walker ID; Thompson CH; McKenzie IF
    Br J Cancer; 1989 Apr; 59(4):544-53. PubMed ID: 2469454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphic epithelial mucin from the sera of advanced breast cancer patients--isolation and partial characterisation.
    O'Sullivan C; Price MR; Baldwin RW
    Br J Cancer; 1990 Jun; 61(6):801-8. PubMed ID: 1695521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.